Annual Interest Expense
$604.00 K
-$84.00 K-12.21%
December 31, 2023
Summary
- As of February 8, 2025, RGLS annual interest expense is $604.00 thousand, with the most recent change of -$84.00 thousand (-12.21%) on December 31, 2023.
- During the last 3 years, RGLS annual interest expense has fallen by -$1.20 million (-66.59%).
- RGLS annual interest expense is now -77.82% below its all-time high of $2.72 million, reached on December 31, 2017.
Performance
RGLS Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$5000.00
-$53.00 K-91.38%
September 30, 2024
Summary
- As of February 8, 2025, RGLS quarterly interest expense is $5000.00, with the most recent change of -$53.00 thousand (-91.38%) on September 30, 2024.
- Over the past year, RGLS quarterly interest expense has dropped by -$53.00 thousand (-91.38%).
- RGLS quarterly interest expense is now -99.50% below its all-time high of $993.00 thousand, reached on December 31, 2017.
Performance
RGLS Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$258.00 K
-$132.00 K-33.85%
September 30, 2024
Summary
- As of February 8, 2025, RGLS TTM interest expense is $258.00 thousand, with the most recent change of -$132.00 thousand (-33.85%) on September 30, 2024.
- Over the past year, RGLS TTM interest expense has dropped by -$132.00 thousand (-33.85%).
- RGLS TTM interest expense is now -90.91% below its all-time high of $2.84 million, reached on September 30, 2018.
Performance
RGLS TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
RGLS Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.2% | -91.4% | -33.9% |
| 3 y3 years | -66.6% | -96.9% | -65.2% |
| 5 y5 years | -74.2% | -99.0% | -83.2% |
RGLS Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.4% | at low | -97.7% | at low | -69.9% | at low |
| 5 y | 5-year | -71.7% | at low | -99.0% | at low | -87.9% | at low |
| alltime | all time | -77.8% | +1577.8% | -99.5% | +110.6% | -90.9% | +1272.7% |
Regulus Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $5000.00(-91.4%) | $258.00 K(-33.8%) |
| Jun 2024 | - | $58.00 K(-28.4%) | $390.00 K(-22.0%) |
| Mar 2024 | - | $81.00 K(-28.9%) | $500.00 K(-17.2%) |
| Dec 2023 | $604.00 K(-12.2%) | $114.00 K(-16.8%) | $604.00 K(-12.0%) |
| Sep 2023 | - | $137.00 K(-18.5%) | $686.00 K(-5.2%) |
| Jun 2023 | - | $168.00 K(-9.2%) | $724.00 K(+0.8%) |
| Mar 2023 | - | $185.00 K(-5.6%) | $718.00 K(+4.4%) |
| Dec 2022 | $688.00 K(-19.5%) | $196.00 K(+12.0%) | $688.00 K(-2.5%) |
| Sep 2022 | - | $175.00 K(+8.0%) | $706.00 K(-4.7%) |
| Jun 2022 | - | $162.00 K(+4.5%) | $741.00 K(-6.8%) |
| Mar 2022 | - | $155.00 K(-27.6%) | $795.00 K(-7.1%) |
| Dec 2021 | $855.00 K(-52.7%) | $214.00 K(+1.9%) | $856.00 K(-17.2%) |
| Sep 2021 | - | $210.00 K(-2.8%) | $1.03 M(-19.8%) |
| Jun 2021 | - | $216.00 K(0.0%) | $1.29 M(-16.0%) |
| Mar 2021 | - | $216.00 K(-44.9%) | $1.53 M(-15.1%) |
| Dec 2020 | $1.81 M(-15.2%) | $392.00 K(-15.9%) | $1.81 M(-5.6%) |
| Sep 2020 | - | $466.00 K(+1.1%) | $1.92 M(-2.6%) |
| Jun 2020 | - | $461.00 K(-5.7%) | $1.97 M(-3.8%) |
| Mar 2020 | - | $489.00 K(-2.2%) | $2.04 M(-4.2%) |
| Dec 2019 | $2.13 M(-9.0%) | $500.00 K(-3.3%) | $2.13 M(+0.2%) |
| Sep 2019 | - | $517.00 K(-3.9%) | $2.13 M(-4.6%) |
| Jun 2019 | - | $538.00 K(-6.9%) | $2.23 M(-3.6%) |
| Mar 2019 | - | $578.00 K(+16.8%) | $2.31 M(-1.2%) |
| Dec 2018 | $2.34 M(-14.0%) | $495.00 K(-20.2%) | $2.34 M(-17.5%) |
| Sep 2018 | - | $620.00 K(-0.2%) | $2.84 M(+1.4%) |
| Jun 2018 | - | $621.00 K(+2.6%) | $2.80 M(+0.6%) |
| Mar 2018 | - | $605.00 K(-39.1%) | $2.78 M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $2.72 M(+130.4%) | $993.00 K(+71.2%) | $2.72 M(+21.7%) |
| Sep 2017 | - | $580.00 K(-3.8%) | $2.24 M(+0.9%) |
| Jun 2017 | - | $603.00 K(+10.4%) | $2.22 M(+30.1%) |
| Mar 2017 | - | $546.00 K(+7.5%) | $1.70 M(+44.2%) |
| Dec 2016 | $1.18 M(+2173.1%) | $508.00 K(-9.3%) | $1.18 M(+67.9%) |
| Sep 2016 | - | $560.00 K(+522.2%) | $704.00 K(+369.3%) |
| Jun 2016 | - | $90.00 K(+275.0%) | $150.00 K(+123.9%) |
| Mar 2016 | - | $24.00 K(-20.0%) | $67.00 K(+31.4%) |
| Dec 2015 | $52.00 K(+33.3%) | $30.00 K(+400.0%) | $51.00 K(+75.9%) |
| Sep 2015 | - | $6000.00(-14.3%) | $29.00 K(-12.1%) |
| Jun 2015 | - | $7000.00(-12.5%) | $33.00 K(-8.3%) |
| Mar 2015 | - | $8000.00(0.0%) | $36.00 K(-7.7%) |
| Dec 2014 | $39.00 K(+8.3%) | $8000.00(-20.0%) | $39.00 K(-7.1%) |
| Sep 2014 | - | $10.00 K(0.0%) | $42.00 K(+7.7%) |
| Jun 2014 | - | $10.00 K(-9.1%) | $39.00 K(-17.0%) |
| Mar 2014 | - | $11.00 K(0.0%) | $47.00 K(+30.6%) |
| Dec 2013 | $36.00 K(-85.4%) | $11.00 K(+57.1%) | $36.00 K(-263.6%) |
| Sep 2013 | - | $7000.00(-61.1%) | -$22.00 K(-127.2%) |
| Jun 2013 | - | $18.00 K(>+9900.0%) | $81.00 K(-47.1%) |
| Mar 2013 | - | $0.00(-100.0%) | $153.00 K(-37.8%) |
| Dec 2012 | $247.00 K(-36.3%) | -$47.00 K(-142.7%) | $246.00 K(-36.6%) |
| Sep 2012 | - | $110.00 K(+22.2%) | $388.00 K(+3.5%) |
| Jun 2012 | - | $90.00 K(-3.2%) | $375.00 K(+31.6%) |
| Mar 2012 | - | $93.00 K(-2.1%) | $285.00 K(+48.4%) |
| Dec 2011 | $388.00 K(+7.2%) | $95.00 K(-2.1%) | $192.00 K(+97.9%) |
| Sep 2011 | - | $97.00 K | $97.00 K |
| Dec 2010 | $362.00 K | - | - |
FAQ
- What is Regulus Therapeutics annual interest expense?
- What is the all time high annual interest expense for Regulus Therapeutics?
- What is Regulus Therapeutics annual interest expense year-on-year change?
- What is Regulus Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly interest expense year-on-year change?
- What is Regulus Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Regulus Therapeutics?
- What is Regulus Therapeutics TTM interest expense year-on-year change?
What is Regulus Therapeutics annual interest expense?
The current annual interest expense of RGLS is $604.00 K
What is the all time high annual interest expense for Regulus Therapeutics?
Regulus Therapeutics all-time high annual interest expense is $2.72 M
What is Regulus Therapeutics annual interest expense year-on-year change?
Over the past year, RGLS annual interest expense has changed by -$84.00 K (-12.21%)
What is Regulus Therapeutics quarterly interest expense?
The current quarterly interest expense of RGLS is $5000.00
What is the all time high quarterly interest expense for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly interest expense is $993.00 K
What is Regulus Therapeutics quarterly interest expense year-on-year change?
Over the past year, RGLS quarterly interest expense has changed by -$53.00 K (-91.38%)
What is Regulus Therapeutics TTM interest expense?
The current TTM interest expense of RGLS is $258.00 K
What is the all time high TTM interest expense for Regulus Therapeutics?
Regulus Therapeutics all-time high TTM interest expense is $2.84 M
What is Regulus Therapeutics TTM interest expense year-on-year change?
Over the past year, RGLS TTM interest expense has changed by -$132.00 K (-33.85%)